This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Pfizer Corporation. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Scott Lawrence Weinrich: Innovator in Cancer Therapy
Introduction
Scott Lawrence Weinrich is a notable inventor based in San Diego, CA. He has made significant contributions to the field of cancer therapy through his innovative work. His research focuses on combination therapies that target specific cancer pathways.
Latest Patents
Scott holds a patent for a "Combination of an anaplastic lymphoma kinase inhibitor and a cyclin dependent kinase inhibitor." This invention relates to combination therapies comprising an inhibitor of anaplastic lymphoma kinase (ALK) and an inhibitor of cyclin dependent kinase 4 and 6 (CDK4/6 inhibitor) or an inhibitor of cyclin dependent kinase 2, 4 and 6 (CDK2/4/6 inhibitor). The patent also covers associated methods of treatment, combinations, pharmaceutical compositions, and uses thereof. He has 1 patent to his name.
Career Highlights
Scott is currently employed at Pfizer Corporation, where he continues to advance his research in oncology. His work is pivotal in developing new treatment options for patients suffering from various forms of cancer.
Collaborations
Scott collaborates with Ping Wei, a fellow researcher, to enhance the effectiveness of their combined efforts in cancer treatment.
Conclusion
Scott Lawrence Weinrich is a dedicated inventor whose work in cancer therapy is making a significant impact in the medical field. His innovative approaches and collaborations are paving the way for new treatment options for patients.